“…Recently, mammalian cell perfusion cultures have regained attraction as an alternative to traditional fed‐batch processes for the production of therapeutic proteins, like monoclonal antibodies (mAbs; Clincke et al, ; Karst, Serra, Villiger, Soos, & Morbidelli, ). Perfusion cultures have been used for the production of unstable proteins (Bödeker, Newcomb, Yuan, Braufman, & Kelsey, ; Warikoo et al, ), and are in general a promising tool for the intensification of protein production processes (Hiller, Ovalle, Gagnon, Curran, & Wang, ; Moulijn, Stankiewicz, Grievink, & Górak, ; Subramanian, ; Xu, Hoshan, & Chen, ; Yang, Minkler, Kshirsagar, & Ryll, ). Particular interest has been directed to their application in the frame of continuous end‐to‐end integrated production processes (Godawat, Konstantinov, Rohani, & Warikoo, ; Karst, Scibona, et al, 2017; Karst, Steinebach, & Morbidelli, ; Karst, Steinebach, Soos, & Morbidelli, ; Steinebach et al, ; Warikoo et al, ).…”